Private Equity in Healthcare - 14/04/25
Doi : 10.1016/j.urology.2025.03.049
Wesley M. White a, ⁎ 
, Abhilash Moolupuri a, Ray Pak b
, Abhilash Moolupuri a, Ray Pak b a Department of Urology, The University of Tennessee Medical Center, Knoxville, TN
b Department of Urology, Mayo Clinic, Jacksonville, FL
⁎Address correspondence to: Wesley M. White, M.D., Department of Urology, The University of Tennessee Medical Center, 1928 Alcoa Highway, B-222, Knoxville, TN 37920.Department of Urology, The University of Tennessee Medical Center1928 Alcoa Highway, B-222KnoxvilleTN37920
In corso di stampa. Prove corrette dall'autore.
Disponibile online dal Monday 14 April 2025
This article has been published in an issue click here to access
This article has been published in an issue click here to access
Riassunto |
Healthcare in the United States is in a time of great transition. Consolidation and corporatization are increasingly normalized. Physician autonomy and self-determination has been deprioritized, contributing to burnout and workforce shortages. One of the most striking and controversial evolutions has been the entry of private equity investment into medicine. In this review article, we will explain the construct of private equity, its rationale for investing in medical practices including urology, and the potential benefits and risks of physician partnership.
Il testo completo di questo articolo è disponibile in PDF.Mappa
© 2025
Elsevier Inc. Tutti i diritti riservati.
Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.
Già abbonato a @@106933@@ rivista ?